CLEAR 1002-043 (Includerend)
A randomized, double-blind, placebo-controlled study to assess the effects of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin intolerant
- Middel
- bepedoic acid
- Populatie
- preventie (cholesterol)
- Fase
- III
- Jaar aanvang
- 2016